Tetra Bio-Pharma Inc. (TBPMQ)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
19,900%
Market Cap 516.00
Revenue (ttm) n/a
Net Income (ttm) -29.84M
Shares Out 515.63M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 80,367
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0000 - 0.0002
Beta 35.28
RSI 40.47
Earnings Date n/a

About Tetra Bio-Pharma

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain. It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome, sepsis and ophthalmic disease. The company is headquartered in Orléans, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 33
Stock Exchange OTCMKTS
Ticker Symbol TBPMQ
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.